当前位置:首页 - 行情中心 - 广济药业(000952) - 财务分析 - 利润表

广济药业

(000952)

  

流通市值:19.74亿  总市值:20.31亿
流通股本:3.44亿   总股本:3.54亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入522,494,180.17343,911,715.83115,290,588.81797,642,746.07
营业收入522,494,180.17343,911,715.83115,290,588.81797,642,746.07
二、营业总成本591,546,752.64367,957,575.68160,483,094.07750,158,562.9
营业成本371,859,575.46237,969,742.9794,210,912.16502,529,957.38
税金及附加9,942,256.146,872,187.364,067,186.9213,498,486.43
销售费用29,027,981.8122,326,741.639,763,244.3333,590,967.28
管理费用104,419,109.3761,800,415.330,938,038.61116,350,655.77
研发费用48,939,908.1827,139,897.0716,432,520.0668,975,628.01
财务费用27,357,921.6811,848,591.355,071,191.9915,212,868.03
其中:利息费用31,929,078.7815,305,830.335,543,903.6821,101,231.6
其中:利息收入2,451,836.721,513,659.36549,769.122,004,865.02
加:投资收益-6,989,585.67-5,094,435.42-2,987,048.926,302,849.46
资产处置收益--0-4,306,827.78
资产减值损失(新)2,315,039.42,677,216.1821,014.24-7,687,838.69
信用减值损失(新)-3,334,681.96-4,040,556.39492,630.31-4,445,730.25
其他收益3,643,520.582,508,522.481,567,640.7223,434,976.87
营业利润平衡项目0000
四、营业利润-73,418,280.12-27,995,113.08-45,298,268.9160,781,612.78
加:营业外收入916,890.2513,056.02306899,420.46
减:营业外支出717,041.53645,473.85520,159.011,597,941.37
利润总额平衡项目0000
五、利润总额-73,218,431.4-28,627,530.91-45,818,121.9260,083,091.87
减:所得税费用-1,424,151.39-501,745.88-419,789.4112,366,487.31
六、净利润-71,794,280.01-28,125,785.03-45,398,332.5147,716,604.56
持续经营净利润-71,794,280.01-28,125,785.03-45,398,332.5147,716,604.56
归属于母公司股东的净利润-66,976,169.88-25,804,539.22-44,038,541.8550,366,243.23
少数股东损益-4,818,110.13-2,321,245.81-1,359,790.66-2,649,638.67
(一)基本每股收益-0.19-0.07-0.120.14
(二)稀释每股收益-0.19-0.07-0.120.14
八、其他综合收益6,19217,360.532,736.716,460.43
归属于母公司股东的其他综合收益6,19217,360.532,736.716,460.43
九、综合收益总额-71,788,088.01-28,108,424.5-45,395,595.847,723,064.99
归属于母公司股东的综合收益总额-66,969,977.88-25,787,178.69-44,035,805.1450,372,703.66
归属于少数股东的综合收益总额-4,818,110.13-2,321,245.81-1,359,790.66-2,649,638.67
公告日期2023-10-212023-08-312023-04-282023-04-20
审计意见(境内)标准无保留意见
TOP↑